Because patient advocacy groups aren’t always what they seem: A quick guide to nonprofit sleuthing from

Filed Under: Costs, Patients, Providers

“Journalists shouldn’t take organizations they report on at face value,” Mary Chris Jaklevic writes over at Health News Review, the watchdog organization. “Rather, they should ask who calls the shots and who provides the funding. And they should report findings that call into question a group’s credibility. But as has repeatedly found, that essential […]

Furor Over Drug Prices Puts Patient Groups in Bind: The New York Times

Filed Under: Costs, Health plans, Patients

Summary: “Public anger over the cost of drugs has burned hot for a year, coursing through social media, popping up on the presidential campaign, and erupting in a series of congressional hearings, including one last week over the rising price of the allergy treatment EpiPen,” writes Katie Thomas at The New York Times. “But one […]